Skip to main content

Leukemia, lymphoma, and myeloma.

265 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Leukemia, lymphoma, and myeloma265 studies

B-Cell LymphomaPhase 1/2NCT05092451Papers

CAR.70/IL15-transduced CB-NK cells

CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

M.D. Anderson Cancer CenterOpen the brief

Recurrent Childhood Acute Myeloid LeukemiaPhase 1NCT06609928Papers

FOLR1 CAR T-cells

FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Fred Hutchinson Cancer CenterOpen the brief

Recurrent Cutaneous T-Cell Non-Hodgkin LymphomaPhase 1/2NCT03011814Papers

Durvalumab

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

City of Hope Medical CenterOpen the brief

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Phase 1/2NCT01371630Papers

Inotuzumab Ozogamicin

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

M.D. Anderson Cancer CenterOpen the brief

Newly Diagnosed Acute Myeloid LeukemiaPhase 1NCT04659616Papers

Pemigatinib After Chemotherapy

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

OHSU Knight Cancer InstituteOpen the brief

Non-Hodgkin LymphomaPhase 1NCT05098613Papers

CD19x22 CAR T Cells

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

University of Colorado, DenverOpen the brief

Multiple MyelomaPhase 1NCT06185751

WS-CART-CS1

CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

Washington University School of MedicineOpen the brief

C-Myc Rearranged High-Grade B-Cell Lymphoma or DLBCLPhase 1/2NCT06249191

Mosunetuzumab + Chemotherapy

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

OHSU Knight Cancer InstituteOpen the brief

Clinical trials: Phase 1 and Phase 2, explained